基本信息
views: 152
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
He specializes in Hemato-Oncology. His research focuses on drug resistance mechanisms in patients with cancer, chemotherapy and targeted therapy of lung cancer, predictive factors in lung cancer, and anemia management in patients with cancer. As a member of the IALT-Bio and LACE-Bio groups, he has been involved in the characterization of predictive factors with regard to adjuvant chemotherapy in patients with completely resected non-small cell Lung Cancer (NSCLC). He was also the worldwide Co-ordinating Investigator of the First-Line Erbitux in lung cancer (FLEX) trial.
Research Interests
Papers共 458 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Fortunato Ciardiello, Fred R. Hirsch,Robert Pirker,Enriqueta Felip,Christian Valencia,Egbert F. Smit
CANCER TREATMENT REVIEWS (2024): 102664-102664
Frontiers in oncology (2024): 1408238-1408238
Current Opinion in Oncology (2023)
CA: a cancer journal for cliniciansno. 6 (2023): 620-652
Current opinion in oncology (2023)
Virchows Archiv : an international journal of pathologyno. 1 (2022): 39-51
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn